Shopping Cart 0
Cart Subtotal
USD 0

Sophia Genetics SA - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sophia Genetics SA (Sophia Genetics) is a health tech company that provides technological solutions such as SOPHiA Artificial Intelligence for clinical genomics and next generation sequencing (NGS) data analysis. The company also provides dry lab, bundle solution, and integrated diagnostic solutions. It offers SOPHiA, a technology that detects, annotates and pre-classifies genomic variants; and SOPHiA DDM, a software-as-a-service platform for routine diagnostic testing. The company facilitates the quick adoption of genomic testing globally, converting data into actionable clinical insights, Its technologies find application in fields such as cardiology, metabolism, pediatrics and hereditary cancers. The company serves clinicians, hospitals and other healthcare institutions. It has a presence in Switzerland and France. Sophia Genetics is headquartered in Saint Sulpice, Switzerland.

Sophia Genetics SA-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sophia Genetics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sophia Genetics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Sophia Genetics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sophia Genetics SA, Medical Equipment, Deal Details 10

Venture Financing 10

Sophia Genetics Raises USD30 Million in Series D Financing 10

Sophia Genetics Raises USD15 Million in Series C Financing 11

Sophia Genetics Raises USD13.8 Million in Series B Venture Financing 12

Sophia Genetics Raises USD3 Million in Series A Venture Financing 13

Sophia Genetics Raises USD1 Million in Seed Financing 14

Partnerships 15

Sophia Genetics Enters into Agreement with Horizon Discovery Group 15

Sophia Genetics Enters into Agreement with Qiagen 16

Sophia Genetics Enters into Agreement with ArcherDx 17

Genohm Enters into Agreement with Interactive Biosoftware 18

Sophia Genetics Enters into Co-Marketing Agreement with Illumina 19

Sophia Genetics Enters into Agreement with Multiplicom 20

Sophia Genetics Enters into Agreement with Integrated DNA 21

Sophia Genetics Enters into Agreement with Swift Biosciences 22

Sophia Genetics SA-Key Competitors 23

Sophia Genetics SA-Key Employees 24

Sophia Genetics SA-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Strategy And Business Planning 26

Sep 24, 2018: SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S. 26

Corporate Communications 27

Jan 11, 2018: SOPHiA GENETICS appoints Valentin Matillon as new Chief Financial Officer 27

Jun 28, 2017: Sophia Genetics Ranked 30th in MIT Technology Review 2017 List of '50 Smartest Companies' 28

Product News 29

Jun 06, 2017: Sophia Artificial Intelligence Empowers Liquid Biopsies To Fight Cancer 29

May 29, 2017: SOPHiA AI Unlocks the Power of Exome Sequencing for Clinical Diagnostics 30

Mar 24, 2017: African Hospitals Adopt Sophia Artificial Intelligence To Trigger Continent-Wide Healthcare Leapfrogging Movement 32

Mar 09, 2017: Sophia Genetics Set To Break Through The Strategic Threshold Of 100K Patients' Genomic Profiles Analyzed By Its Artificial Intelligence Sophia 33

Other Significant Developments 35

Jan 24, 2018: IA Sophia Integrates Radiology Expertise Of French Mathematician Thierry Colin 35

Oct 11, 2017: Mexico Embraces the Clinical Genomics Movement with Six Institutions Now Using Sophia AI 36

Feb 13, 2017: Sophia AI Becomes the Technology of Choice for Clinical Diagnostic in Latin America 38

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Sophia Genetics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sophia Genetics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sophia Genetics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sophia Genetics SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Sophia Genetics SA, Medical Equipment, Key Facts 2

Sophia Genetics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Sophia Genetics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Sophia Genetics SA, Deals By Market, 2012 to YTD 2018 8

Sophia Genetics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Sophia Genetics Raises USD30 Million in Series D Financing 10

Sophia Genetics Raises USD15 Million in Series C Financing 11

Sophia Genetics Raises USD13.8 Million in Series B Venture Financing 12

Sophia Genetics Raises USD3 Million in Series A Venture Financing 13

Sophia Genetics Raises USD1 Million in Seed Financing 14

Sophia Genetics Enters into Agreement with Horizon Discovery Group 15

Sophia Genetics Enters into Agreement with Qiagen 16

Sophia Genetics Enters into Agreement with ArcherDx 17

Genohm Enters into Agreement with Interactive Biosoftware 18

Sophia Genetics Enters into Co-Marketing Agreement with Illumina 19

Sophia Genetics Enters into Agreement with Multiplicom 20

Sophia Genetics Enters into Agreement with Integrated DNA 21

Sophia Genetics Enters into Agreement with Swift Biosciences 22

Sophia Genetics SA, Key Competitors 23

Sophia Genetics SA, Key Employees 24

Sophia Genetics SA, Subsidiaries 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sophia Genetics SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.